vaginal atrophy. Menopausal and female climacteric states
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Entering menopause Genitourinary syndrome in menopause women Vaginal pH higher than 5 No clinical history of malignancy or atypia Normal vaginal examination
Exclusion criteria
Exclusion criteria: History of hormone therapy for at least six months Pacemaker implantation History of implanting any metal device in the body History of hemophilia or other bleeding disorders Current diagnosis of vaginal infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dysuria. Timepoint: The effect of intravaginal radiofrequency on improving dysuria at pre-intervention, two weeks after the intervention, six months after the intervention, and twelve months after the intervention. Method of measurement: Urinary symptoms: including pain and burning after urination, occurrence of urinary or vaginal infections, using the UDI6 questionnare .;Sexual function. Timepoint: The effect of intravaginal radiofrequency on sexual function at the stages before the intervention, two weeks after the intervention, six months after the intervention, and twelve months after the intervention. Method of measurement: Assessing sexual function with the Women's Sexual Function Index (FSFI) questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences